Comparison between Nukleus Office Solutions IPO and Royal Arc Electrodes IPO.
Nukleus Office Solutions IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Royal Arc Electrodes IPO is a SME Bookbuilding proposed to list at NSE SME.
| Nukleus Office Solutions IPO | Royal Arc Electrodes IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Sundae Capital Advisors Pvt.Ltd. | Fedex Securities Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | Shreni Shares Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Nukleus Office Solutions IPO is up to ₹23.67 Cr whereas the issue size of the Royal Arc Electrodes IPO is up to ₹34.16 Cr. The final issue price of Nukleus Office Solutions IPO is ₹234.00 per share and of Royal Arc Electrodes IPO is ₹120.00 per share.
| Nukleus Office Solutions IPO | Royal Arc Electrodes IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹114.00 per share | |
| Issue Price (Upper) | ₹120.00 per share | |
| Issue Price (Final) | ₹234.00 per share | ₹120.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 600 shares | 1200 shares |
| Fresh Issue Size | 10,11,600 shares | 16,46,400 shares |
| Fresh Issue Size (Amount) | up to ₹23.67 Cr | up to ₹19.76 Cr |
| OFS Issue Size | 0 shares | 12,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹14.40 Cr |
| Issue Size Total | 10,11,600 shares | 28,46,400 shares |
| Issue Size Total (Amount) | up to ₹23.67 Cr | up to ₹34.16 Cr |
Nukleus Office Solutions IPO opens on Feb 24, 2025, while Royal Arc Electrodes IPO opens on Feb 14, 2025. The closing date of Nukleus Office Solutions IPO and Royal Arc Electrodes IPO is Feb 27, 2025, and Feb 18, 2025, respectively.
| Nukleus Office Solutions IPO | Royal Arc Electrodes IPO | |
|---|---|---|
| Anchor Bid Date | Feb 13, 2025 | |
| Issue Open | Feb 24, 2025 | Feb 14, 2025 |
| Issue Close | Feb 27, 2025 | Feb 18, 2025 |
| Basis Of Allotment (Tentative) | Feb 28, 2025 | Feb 19, 2025 |
| Initiation of Refunds (Tentative) | Mar 03, 2025 | Feb 20, 2025 |
| Credit of Share (Tentative) | Mar 03, 2025 | Feb 20, 2025 |
| Listing date (Tentative) | Mar 04, 2025 | Feb 24, 2025 |
| Anchor Lockin End date 1 | Mar 21, 2025 | |
| Anchor Lockin End date 2 | May 20, 2025 |
Nukleus Office Solutions IPO P/E ratio is 52.33, as compared to Royal Arc Electrodes IPO P/E ratio of 9.36.
| Nukleus Office Solutions IPO | Royal Arc Electrodes IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Nukleus Office Solutions Limited Financial Information (Restated)
| Royal Arc Electrodes Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.98 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.28 | 72.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 52.33 | 9.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹94.35 Cr. | ₹133.20 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 46.09% | 32.85% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.39% | 37.73% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.96 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.47 | ₹12.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 46.09% | 28.21% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Nukleus Office Solutions IPO Retail Individual Investors (RII) are offered 5,05,800 shares while in Royal Arc Electrodes IPO retail investors are offered 5,05,800 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Nukleus Office Solutions IPO and 5,82,000 shares in Royal Arc Electrodes IPO.
| Nukleus Office Solutions IPO | Royal Arc Electrodes IPO | |
|---|---|---|
| Anchor Investor Reserveration | 0 shares | 8,40,000 shares |
| Market Maker Reserveration | 53,400 shares | 1,53,600 shares |
| QIB | 0 shares | 5,82,000 shares |
| NII | 5,05,800 shares | 4,06,800 shares |
| RII | 5,05,800 shares | 10,17,600 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 10,11,600 shares | 28,46,400 shares |
Nukleus Office Solutions IPO subscribed 1.29x in total, whereas Royal Arc Electrodes IPO subscribed 1.60x.
| Nukleus Office Solutions IPO | Royal Arc Electrodes IPO | |
|---|---|---|
| QIB (times) | 1.04x | |
| NII (times) | 0.87x | 0.92x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.70x | 2.20x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.29x | 1.60x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
